PharmaGroup ApS: Financial statements 2025
CVR: 43324667
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PharmaGroup ApS (CVR 43324667) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,561,227 and a net result of DKK 2,366,747 compared with DKK 5,037,144 the year before. That is a decrease of 38.5% compared with the year before. Equity in the 2025 report amounted to DKK 2,458,279. The solvency ratio was 63.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 5,561,227
- Profit/Loss
- DKK 2,366,747
- Equity
- DKK 2,458,279
- Total Assets
- DKK 3,888,448
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 5.6M | 2.4M | 2.5M | 3 |
| 2024 | - | 9M | 5M | 5.1M | 4 |
| 2023 | - | 8.8M | 5.4M | 7.3M | 2 |
| 2022 | - | 3M | 1M | 1.8M | 1 |
Official annual report
How creditworthy is PharmaGroup ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PharmaGroup ApS has published its annual report for 2024. Gross profit came to DKK 9,046,929, and the net result was DKK 5,037,144.
As of April 24, 2025, KOA CPH ApS has been appointed auditor of PharmaGroup ApS.
About PharmaGroup ApS
PharmaGroup ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2022. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Amar Fakhry Alaa Al Dyen-Ahmad. The company is owned by PharmaGroup Holding ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 5,561,227 and a net result of DKK 2,366,747 compared with DKK 5,037,144 the year before. Equity in the 2025 report amounted to DKK 2,458,279.